| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/16/1999 | US5985262 Method of treatment with epithelium derived T-cell factor |
| 11/16/1999 | US5985242 Peptide of 3 to 5 d-amino acids; may be modified at amino-and/or carboxy terminus; for treatment of amyloidosis, alzheimer's disease |
| 11/16/1999 | US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide |
| 11/16/1999 | US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis, |
| 11/16/1999 | US5985037 Mixing colloidal silica sol with nondialyzable polyvinylpyrrolidone coating and sugar to dissolve, transferring to centrifuge tube, applying centrifugal force to form linear gradient |
| 11/16/1999 | CA2217668C Genetic markers for breast and ovarian cancer |
| 11/16/1999 | CA2088600C Herpes simplex virus vp16 vaccines |
| 11/16/1999 | CA2072007C Cloning vector for use in lactic acid bacteria and a method for constructing the same |
| 11/16/1999 | CA2056402C Therapeutic agent |
| 11/16/1999 | CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates |
| 11/16/1999 | CA2008698C Male flower specific gene sequences |
| 11/16/1999 | CA2005926C Process for immobilising a protein on a solid phase |
| 11/16/1999 | CA2003360C Human vascular permeability factor |
| 11/16/1999 | CA1340824C Neurokinin a antagonists |
| 11/16/1999 | CA1340823C Insulin precursors, process for their preparation and process for the preparation of human insulin |
| 11/13/1999 | CA2248987A1 Novel compounds |
| 11/12/1999 | CA2270425A1 Amino acid sequence |
| 11/11/1999 | WO1999057565A2 Methods for diagnosing and evaluating cancer |
| 11/11/1999 | WO1999057536A2 Cyclin activation kinase (cak) from human pathogens, and uses related thereto |
| 11/11/1999 | WO1999057535A2 Recombinant cell line and screening method for identifying agents which regulate apoptosis and tumor suppression |
| 11/11/1999 | WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 11/11/1999 | WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof |
| 11/11/1999 | WO1999057293A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
| 11/11/1999 | WO1999057292A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
| 11/11/1999 | WO1999057291A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
| 11/11/1999 | WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 11/11/1999 | WO1999057289A2 INHIBIN-HBc FUSION PROTEIN |
| 11/11/1999 | WO1999057284A2 Attenuated influenza viruses |
| 11/11/1999 | WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 11/11/1999 | WO1999057282A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 11/11/1999 | WO1999057281A2 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same |
| 11/11/1999 | WO1999057280A2 Neisseria meningitidis antigens and compositions |
| 11/11/1999 | WO1999057279A1 Plasmid for gene expression in pichia ciferrii and transformation method using the same |
| 11/11/1999 | WO1999057278A2 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
| 11/11/1999 | WO1999057277A2 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 11/11/1999 | WO1999057276A1 Multifunctional adhesin proteins and their display in microbial cells |
| 11/11/1999 | WO1999057274A1 Human protease associated proteins |
| 11/11/1999 | WO1999057273A2 Cytoplasmic antiproteinase-3 coding sequence in gene therapy |
| 11/11/1999 | WO1999057272A1 Peptide inhibitors of hiv replication |
| 11/11/1999 | WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 11/11/1999 | WO1999057270A2 Human receptor molecules |
| 11/11/1999 | WO1999057269A1 Human hrpi |
| 11/11/1999 | WO1999057268A1 Chimeric receptors |
| 11/11/1999 | WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 11/11/1999 | WO1999057263A1 Modifying the expression of the fsh beta gene by homologous recombination |
| 11/11/1999 | WO1999057261A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 11/11/1999 | WO1999057251A2 Thrombolytic agents derived from streptokinase |
| 11/11/1999 | WO1999057247A1 Nucleic acids that control seed and fruit development in plants |
| 11/11/1999 | WO1999057245A1 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof |
| 11/11/1999 | WO1999057241A2 Myelin basic protein peptides and uses thereof |
| 11/11/1999 | WO1999057157A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 11/11/1999 | WO1999057155A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 11/11/1999 | WO1999057150A2 Multivalent antibody constructs |
| 11/11/1999 | WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 11/11/1999 | WO1999057148A1 Melanocortin 1 receptor selective compounds |
| 11/11/1999 | WO1999057147A1 Human thrombopoietin mutants |
| 11/11/1999 | WO1999057146A1 Protein mixtures to induce therapeutic angiogenesis |
| 11/11/1999 | WO1999057145A2 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
| 11/11/1999 | WO1999057144A2 Human transcriptional regulator molecules |
| 11/11/1999 | WO1999057143A1 Transcriptional regulatory factor |
| 11/11/1999 | WO1999057142A2 Vaccine for $i(pseudomonas aeruginosa) |
| 11/11/1999 | WO1999057141A1 Immunodiagnostic reagent for the detection of maedi-visna virus and caev infection |
| 11/11/1999 | WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor |
| 11/11/1999 | WO1999057139A2 Pth2 receptor selective compounds |
| 11/11/1999 | WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof |
| 11/11/1999 | WO1999057137A1 Compositions and methods involving regulation of mammalian circadian rhythms |
| 11/11/1999 | WO1999057133A2 Inhibitors of nf-kb activation |
| 11/11/1999 | WO1999057132A1 Secreted proteins and polynucleotides encoding them |
| 11/11/1999 | WO1999057131A1 Method of treating bladder and lower urinary tract syndromes |
| 11/11/1999 | WO1999057129A1 Pathogeniv tau mutations |
| 11/11/1999 | WO1999057128A1 Optimization of pest resistance genes using dna shuffling |
| 11/11/1999 | WO1999056850A1 Chelate-forming filter, process for producing the same, and method of purifying liquid with the filter |
| 11/11/1999 | WO1999056784A2 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
| 11/11/1999 | WO1999056778A1 The cytokine family member, 2-19 |
| 11/11/1999 | WO1999056775A1 Use of interleukin-18 as vaccine adjuvant |
| 11/11/1999 | WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements |
| 11/11/1999 | WO1999056769A2 Inhibition of helicobacter pylori proliferation |
| 11/11/1999 | WO1999056767A2 Method for treating cytokine mediated hepatic injury |
| 11/11/1999 | WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses |
| 11/11/1999 | WO1999056723A2 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 11/11/1999 | WO1999056700A2 Avian polyomavirus vaccines in psittacine birds |
| 11/11/1999 | WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 11/11/1999 | WO1999049064A3 Plant control genes |
| 11/11/1999 | WO1999048348A8 Helicobacter pylori derived factor which inhibits ena-78 secretion |
| 11/11/1999 | WO1999047677A3 Polypeptides homologous to vegf and bmp1 |
| 11/11/1999 | WO1999047563A3 Ribonucleotide polypeptides containing metal |
| 11/11/1999 | WO1999045031A9 Cd147 binding molecules as therapeutics |
| 11/11/1999 | WO1999042821A3 Treating cancer |
| 11/11/1999 | WO1999042574B1 Sequences of an ih ionic channel and the use thereof |
| 11/11/1999 | WO1999041608A3 Interaction between cyclin d1 and steroid receptor co-activators |
| 11/11/1999 | WO1999041402A3 Targeting of genetic vaccine vectors |
| 11/11/1999 | WO1999040214A3 Nucleic acid delivery vehicles |
| 11/11/1999 | WO1999037778A3 Compositions and methods for detecting and treating prostate cancer |
| 11/11/1999 | WO1999036542A8 Gene associated with disease resistance in plants |
| 11/11/1999 | WO1999035169A9 Methods and compositions for treating and diagnosing insulin related disorders |
| 11/11/1999 | WO1999029863A9 Human interferon-epsilon: a type i interferon |
| 11/11/1999 | WO1999028464A3 Cdnas and proteins belonging to the bhlh-pas superfamily of transcription regulators and methods of use |
| 11/11/1999 | WO1999027105A3 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 11/11/1999 | WO1999022773B1 Sequences for targeting metastatic cells |
| 11/11/1999 | DE19819846A1 Multivalente Antikörper-Konstrukte Multivalent antibody constructs |